BarryJoelGertzMD

Endocrinology • Rahway, NJ

Diabetes, Lipid Metabolism

Physician

Join to view full profile

Dr. Gertz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gertz's full profile

Already have an account?

Office
126 E Lincoln Ave
Rahway, NJ 07065
Phone+1 732-594-5410

Fax+1 732-594-7310

Education & Training

University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 1983 - 1985
University of California (San Francisco)Fellowship, Endocrinology, Diabetes, and Metabolism, 1982 - 1983
University of Pennsylvania Health SystemResidency, Internal Medicine, 1979 - 1982
Perelman School of Medicine at the University of PennsylvaniaClass of 1979

Certifications & Licensure

CA State Medical License 1982 - Present
NY State Medical License 1986 - 2026
NJ State Medical License 1988 - 2015
PA State Medical License 1981 - 1990
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Publications & Presentations

PubMed

4 citations
Safety and Efficacy of Long-Term Deutetrabenazine Use in Children and Adolescents with Tics Associated with Tourette Syndrome: An Open-Label Extension Study.
Joseph Jankovic, Barbara Coffey, Daniel O Claassen, Joohi Jimenez-Shahed, Barry J Gertz
Movement Disorders Clinical Practice. 2023-09-01
19 citations
Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial.
Joseph Jankovic, Barbara J. Coffey, Daniel O. Claassen, Joohi Jimenez-Shahed, Barry J Gertz
JAMA Network Open. 2021-10-01
17 citations
Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial.
Barbara J. Coffey, Joseph Jankovic, Daniel O. Claassen, Joohi Jimenez-Shahed, Barry J Gertz
JAMA Network Open. 2021-10-01

Press Mentions

Clarus Promotes Dr. Emmett Cunningham to Managing Director, Dr. Barry Gertz to Partner, and Dr. Ari Brettman to PrincipalJanuary 6th, 2017